INSM
Insmed Incorporated · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders -6.7% ·
aandelenstroom -9.5% ·
netto nieuwe posities -7.1%
— formule
Brede distributie — dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 158 | -6 | 147.56M | $15.74B | +6 | −11 |
| Q1 2026 | 166 | +6 | 152.11M | $24.63B | +9 | −4 |
| Q4 2025 | 159 | -1 | 156.45M | $27.23B | +1 | −1 |
| Q3 2025 | 21 | +1 | 121.03M | $17.43B | +1 | −1 |
| Q2 2025 | 18 | +1 | 70.35M | $7.08B | +2 | −1 |
| Q1 2025 | 14 | -1 | 33.99M | $2.59B | — | −1 |
| Q4 2024 | 15 | 0 | 31.46M | $2.17B | +1 | −1 |
| Q3 2024 | 14 | -1 | 23.46M | $1.71B | — | −1 |
| Q2 2024 | 15 | — | 25.91M | $1.74B | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 12.58M | +3.4% | $918.41M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 12.58M | +3.4% | $918.41M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passief) | 3.81M | +4.7% | $278.43M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passief) | 3.81M | +4.7% | $278.43M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Norges Bank ✦ (passief) | 1.66M | -5.7% | $120.94M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Adage Capital Partners ✦ | 1.03M | -22.1% | $75.38M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 962.46K | +2.6% | $70.26M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 962.46K | +2.6% | $70.26M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 962.46K | +2.6% | $70.26M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Wellington Management ✦ | 962.46K | +2.6% | $70.26M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Wellington Management ✦ | 962.46K | +2.6% | $70.26M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Wellington Management ✦ | 962.46K | +2.6% | $70.26M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 801.14K | +643.6% | $58.48M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 14 | Marshall Wace ✦ | 771.21K | -38.3% | $56.30M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 15 | Millennium Management ✦ | 564.86K | -52.9% | $41.23M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | Millennium Management ✦ | 564.86K | -52.9% | $41.23M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Soros Fund Management ✦ | 478.60K | +1.7% | $34.94M | 1.0% | ▲ Add | 2 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 336.56K | -57.9% | $24.57M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Citadel Advisors ✦ | 336.56K | -57.9% | $24.57M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | Point72 Asset Management ✦ | 315.15K | -63.3% | $23.01M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 21 | D. E. Shaw & Co. ✦ | 66.73K | -76.9% | $4.87M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 22 | D. E. Shaw & Co. ✦ | 66.73K | -76.9% | $4.87M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 62.88K | +3.9% | $4.59M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 62.88K | +3.9% | $4.59M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 25 | Duquesne Family Office ✦ | 20.00K | 0.0% | $1.46M | 0.1% | Held | 2 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Viking Global Investors | $69.41M | was 0.3% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 664 houders, 192.22M aandelen, $30.07B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Director · 5.00K aand · $637,650
Officer · 239.85K aand · $31.96M
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie